International Network of VENous Thromboembolism Clinical Research Networks

RENOVE

REduced dose versus full-dose of direct oral anticoagulant after uNprOvoked Venous thromboEmbolism. The RENOVE open-label, randomized, controlled trial

Registration:

EudraCT2017-002433-31

(Clinicaltrials.gov) NCT03285438

Sponsors:

Brest University Hospital

Brest, France

Status:

  • Seeking sites and collaborators

Design

Open-label RCT comparing a reduced dose versus full-dose of direct oral anticoagulant after unprovoked venous thromboembolism

Participating Sites

INNOVTE logo

Lead Network:

INNOVTE
Flag of France

Countries:

France

Lead Investigators

Pr. Francis Couturaud, MD

francis.couturaud@chu-brest.fr

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.